Efficacy Analysis of Indaterol in the Treatment of COPD
LIN Hong-chao
Abstract：Objective To investigate the clinical efficacy and safety of Indatero in the treatment of COPD.Methods Through adopting randomized controlled trial,80 patients were randomly divided into A and B groups,with 40 patients in each group.Patients in A Group were delivered Indaterol treatment while Group B patients were delivered formoterol treatment.In the follow-up after 1 d, 30 d and 90 d, the clinical efficacy was evaluated and the safety was monitored before and after the treatment.Results 1 d,30 d and 90 d after the treatment, the FEV1 of patients in Group A were higher than those in Group B,and the FEV1 improvement in Group A were larger than those in Group B(P<0.05);BODE index in Group A was lower than those in group B, and the BODE index decrease in Group A was larger than those in Group B(P<0.05);SGRO score in Group A was lower than those in Group B, and the Group A score decrease was larger than that in Group B(P<0.05);the adverse events in A and B Groups didn′t have obvious difference(P>0.05).Conclusion Indene Datlow has fast reaction,continuous and stable clinical efficacy, and high security.It can obviously improve the pulmonary ventilation function,condition and living quality,which makes it worthy of clinical application and popularization.
Keywords：IndateroFormoterolCOPD
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 250-253 )